Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 77

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction

Govier, Fred, Potempa, Axel-Juerg, Kaufman, Joel, Denne, Jonathan, Kovalenko, Pavel, Ahuja, Sanjeev·2003·Clinical Therapeutics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0149-2918(03)80328-4

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 24

  1. McKinlay, 2000, The worldwide prevalence and epidemiology of erectile dysfunction, Int J Impot Res, 12, S6, 10.1038/sj.ijir.3900567 · DOI · Paper page
  2. Litwin, 1998, Health-related quality of life in men with erectile dysfunction, J Gen Intern Med, 13, 159, 10.1046/j.1525-1497.1998.00050.x · DOI · Paper page
  3. Rust, 1988, Marital problems and sexual dysfunction: How are they related?, Br J Psychiatry, 152, 629, 10.1192/bjp.152.5.629 · DOI
  4. NIH Consensus Development Panel on Impotence, 1993, 270, 83
  5. Aytaç, 1999, The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences, BJU Int, 84, 50, 10.1046/j.1464-410x.1999.00142.x · DOI · Paper page
  6. Burchardt, 2001, Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension, Int J Impot Res, 13, 276, 10.1038/sj.ijir.3900725 · DOI
  7. Kirby, 2001, Is erectile dysfunction a marker for cardiovascular disease?, Int J Clin Pract, 55, 614, 10.1111/j.1742-1241.2001.tb11141.x · DOI
  8. Buvat, 1985, Comparative investigations in 26 impotent and 26 nonimpotent diabetic patients, J Urol, 133, 34, 10.1016/S0022-5347(17)48773-8 · DOI
  9. O'Kane, 2001, Erectile dysfunction: Is there silent obstructive coronary artery disease?, Int J Clin Pract, 55, 219
  10. Hanash, 1997, Comparative results of goal oriented therapy for erectile dysfunction, J Urol, 157, 2135, 10.1016/S0022-5347(01)64695-0 · DOI
  11. Jarow, 1996, Outcome analysis of goal directed therapy for impotence, J Urol, 155, 1609, 10.1016/S0022-5347(01)66142-1 · DOI
  12. Brock, 2002, Efficacy and safety of tadalafil in the treatment of erectile dysfunction: Results of integrated analyses, J Urol, 168, 1332, 10.1016/S0022-5347(05)64442-4 · DOI · Paper page
  13. Fink, 2002, Sildenafil for male erectile dysfunction: A systematic review and meta-analysis, Arch Intern Med, 162, 1349, 10.1001/archinte.162.12.1349 · DOI
  14. Morales, 1998, Clinical safety of oral sildenafil citrate (VIAGRA™) in the treatment of, Int J Impot Res, 10, 69, 10.1038/sj.ijir.3900354 · DOI · Paper page
  15. Hanson-Divers, 1998, Health outcomes variables important to patients in the treatment of erectile dysfunction, J Urol, 159, 1541, 10.1097/00005392-199805000-00037 · DOI
  16. Jarow, 1999, Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment, J Urol, 162, 722, 10.1097/00005392-199909010-00024 · DOI
  17. Hatzichristou, 2000, Sildenafil versus intracavernous injection therapy: Efficacy and preference in patients on intracavernous injection for more than 1 year, J Urol, 164, 1197, 10.1016/S0022-5347(05)67140-6 · DOI
  18. McMahon, 2000, Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction, J Urol., 164, 1192, 10.1016/S0022-5347(05)67139-X · DOI
  19. Giuliano, 2000, Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: Results of a multicenter European study, J Urol., 164, 708, 10.1016/S0022-5347(05)67286-2 · DOI
  20. Fagelman, 2001, Efficacy, safety, and use of sildenafil in urologic practice, Urology, 57, 1141, 10.1016/S0090-4295(01)00984-0 · DOI
  21. Martinez-Jabaloyas, 2001, Prognostic factors for response to sildenafil in patients with erectile dysfunction, Eur Urol., 40, 641, 10.1159/000049850 · DOI
  22. Paige, 2001, Improvement in emotional well-being and relationships of users of sildenafil, J Urol., 166, 1774, 10.1016/S0022-5347(05)65673-X · DOI
  23. Marks, 1999, Treatment of erectile dysfunction with sildenafil, Urology, 53, 19, 10.1016/S0090-4295(98)00525-1 · DOI
  24. Wagner, 2001, Sildenafil citrate (Viagra®) improves erectile function in elderly patients with erectile dysfunction: A subgroup analysis, J Gerontol A Biol Sci Med Sci., 56, M113, 10.1093/gerona/56.2.M113 · DOI

Cited by

See all 77

Metadata

Authors
Govier, F., Potempa, A.-J., Kaufman, J., Denne, J., Kovalenko, P., & Ahuja, S.
Venue
Clinical Therapeutics
Publisher
Elsevier BV
Published
2003-11
Volume
25
Issue
11
Pages
2709-2723
ISSN
0149-2918
Cited by
77
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction. https://app.cochat.ai/papers/10.1016/s0149-2918(03)80328-4
The paper
Govier, F., Potempa, A.-J., Kaufman, J., Denne, J., Kovalenko, P., & Ahuja, S. (2003). A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction. Clinical Therapeutics. https://doi.org/10.1016/s0149-2918(03)80328-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.